Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial - Merz, Maximilian; Mai, Elias K.; Bertsch, Uta; Hose, Dirk; Seckinger, Anja; Jauch, Anna; Hillengaß, Jens; Raab, Marc-Steffen; Schurich, Bärbel; Goldschmidt, Hartmut (Haematologica, 2016)
Gesehen am 26.09.2017